Call Today: 800-889-3898
Submit your Digitek claim details for a free, no obligation case review
Get Started:
On May 11, the drug repackaging company A-S Medical Solutions announced that they are recalling all 0.25-mg digoxin tablets labeled as "Caraco" brand. The tablets may differ from the correct size and dosage, putting patients at risk of digoxin toxicity, a life-threatening condition.
The recalled tablets were distributed before March 31, 2009 and have an expiration date of or prior to August 2011. The tablets are white, round and biconvex, imprinted with numbers. The 0.25-mg tablets come in 30-tablet packages labeled "Digoxin, USP, 0.25 mg". The manufacturer of the tablets, Detroit-based Caraco Pharmaceutical Laboratories, Ltd., issued the recall down to the consumer level (this means that at least some of the tablets are in the possession of patients — not just pharmacies or hospitals).
The Caraco digoxin tablets are prescribed as a treatment for abnormal heart rhythms and heart failure. The symptoms of digoxin overdose are:
A digoxin overdose can be fatal. Individuals with impaired renal (kidney) function are especially at risk, since their kidneys may not clear the excess digoxin.
The U.S. Food and Drug Administration (FDA) has confirmed the digoxin recall, and asks that physicians and patients who observe any adverse reactions to the digoxin tablets report them to the FDA's MedWatch Program (the nationwide clearinghouse for medical product safety reporting).
Patients taking digoxin who have any questions should also contact their physicians. For further information about the legal ramifications of this recall, interested individuals can discuss their concerns with a digitek lawyer who represents people harmed by defective drugs. Contact a product liability lawyer near you to learn more about the latest digoxin recall.